Chris Lewis
Stock Analyst at Roth Capital
(3.09)
# 1,245
Out of 4,915 analysts
13
Total ratings
77.78%
Success rate
62.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $9.26 | -56.80% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $58.34 | -72.57% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $13.09 | +10.77% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $46.95 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $1.30 | +1,438.46% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $9.26
Upside: -56.80%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $58.34
Upside: -72.57%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $13.09
Upside: +10.77%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $46.95
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.30
Upside: +1,438.46%